The Problem of Antimicrobial Resistance through the Production of Beta-Lactamases

Antimicrobial resistance is a multifaceted phenomenon influenced by a variety of causes. It is seen as an evolution in action in bacteria, with numerous genetic mechanisms developing as a result of selective pressure in conjunction with antibiotic usage and misuse. The ability of the organism to cope with the resistance mechanism, the initial colonization site, and the resistance it exhibits are all elements that contribute to the development of resistance. Beta-lactamase synthesis is the most important mechanism of resistance to beta-lactam antibiotics posed by Gram-negative bacteria. The beta-lactam antibiotics are one of the most widely used antimicrobial agents with a positive impact in treating bacterial infections globally. They exert their antibacterial activity by inhibiting bacterial cell wall synthesis. These antibiotics include penicillins, cephalosporins, monobactams, and carbapenems. Due to the widespread use and misapplication of these antibiotics, resistance to them is forming and growing exponentially, jeopardizing the ability to treat infectious diseases, which can lead to severe illness, damage, and death. This review focuses on the problem posed by the production of the beta-lactamase enzyme, novel therapies to combat antimicrobial resistance due to beta-lactamase production, and factors to consider in regulating this global threat.